SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-013173 to Basel Medical Group Ltd (BMGL)

Basel Medical Group Ltd
Date: Nov. 27, 2024 · CIK: 0002004489 · Accession: 0000000000-24-013173

AI Filing Summary & Sentiment

File numbers found in text: 333-282096

Date
November 27, 2024
Author
Not clearly detected
Form
UPLOAD
Company
Basel Medical Group Ltd

Letter

November 27, 2024 Raymond Wai Man Cheung Chief Executive Officer Basel Medical Group Ltd 6 Napier Road Unit #02-10/11 Gleneagles Medical Centre Singapore 258499 Re:Basel Medical Group Ltd Amendment No. 2 to Registration Statement on Form F-1 Filed November 14, 2024 File No. 333-282096 Dear Raymond Wai Man Cheung: We have reviewed your amended registration statement and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Amendment No. 2 to Form F-1 filed November 14, 2024 Selling Shareholders, page 3 1.We refer to your selling shareholder table on page Alt-3. Please revise your disclosure to provide additional details regarding the transaction in which the selling shareholders acquired their shares, including the date on which the transaction was completed and the material terms of the agreements relating to such transaction. Please file the agreements as exhibits to the registration statement or tell us why you believe you are not required to do so. Refer to Item 601(b)(10) of Regulation S-K. Please contact Nudrat Salik at 202-551-3692 or Michael Fay at 202-551-3812 if you have questions regarding comments on the financial statements and related matters. Please

November 27, 2024 Page 2 contact Robert Augustin at 202-551-8483 or Jane Park at 202-551-7439 with any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Benjamin Tan, Esq.

Show Raw Text
November 27, 2024
Raymond Wai Man Cheung
Chief Executive Officer
Basel Medical Group Ltd
6 Napier Road
Unit #02-10/11 Gleneagles Medical Centre
Singapore 258499
Re:Basel Medical Group Ltd
Amendment No. 2 to Registration Statement on Form F-1
Filed November 14, 2024
File No. 333-282096
Dear Raymond Wai Man Cheung:
            We have reviewed your amended registration statement and have the following
comment.
            Please respond to this letter by amending your registration statement and providing
the requested information. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information
you provide in response to this letter, we may have additional comments.
Amendment No. 2 to Form F-1 filed November 14, 2024
Selling Shareholders, page 3
1.We refer to your selling shareholder table on page Alt-3. Please revise your disclosure
to provide additional details regarding the transaction in which
the selling shareholders acquired their shares, including the date on which the
transaction was completed and the material terms of the agreements relating to such
transaction. Please file the agreements as exhibits to the registration statement or tell
us why you believe you are not required to do so. Refer to Item 601(b)(10) of
Regulation S-K.
            Please contact Nudrat Salik at 202-551-3692 or Michael Fay at 202-551-3812 if you
have questions regarding comments on the financial statements and related matters. Please

November 27, 2024
Page 2
contact Robert Augustin at 202-551-8483 or Jane Park at 202-551-7439 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Benjamin Tan, Esq.